Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 583
interventional 503
Observational 72
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 181
Drug|placebo 154
Other 34
Biological|placebo 23
Device 15
Biological 13
Behavioral 11
Device|Drug 11
Drug|Other 11
Dietary Supplement|placebo 10
Dietary Supplement 7
Drug|Other|placebo 4
Other|placebo 4
Procedure 4
Device|placebo 3
Behavioral|Drug 2
Behavioral|Other 2
Device|Other 2
Behavioral|Drug|Other 1
Biological|Drug 1
Biological|Drug|placebo 1
Biological|Other|placebo 1
Combination Product|Drug 1
Device|Drug|Other 1
Diagnostic Test 1
Dietary Supplement|Other 1
Genetic 1
Other|Procedure 1
placebo 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 157
Germany 41
NA 20
United Kingdom 19
United States|Canada 18
Japan 17
Korea, Republic of 12
Canada 9
Taiwan 9
China 8
France 8
Netherlands 7
Sweden 6
Switzerland 6
Denmark 5
South Africa 5
Spain 5
Brazil 4
Italy 4
Australia 3
Finland 3
Norway 3
Singapore 3
Thailand 3
Austria 2
Belgium|Germany 2
Estonia|France|Lithuania|Poland|Romania 2
Germany|Netherlands 2
Ireland 2
Israel 2
Mexico 2
Russian Federation 2
United States|Australia|Canada 2
United States|Canada|Japan 2
United States|Canada|Puerto Rico 2
United States|Germany|Poland 2
United States|Japan 2
United States|Netherlands 2
Argentina|Australia|Austria|Brazil|Czechia|France|Germany|Hungary|India|Israel|Japan|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
Argentina|Australia|Austria|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan 1
Argentina|Australia|Austria|Hungary|Israel|Japan|Korea, Republic of|Poland|Spain|Switzerland 1
Australia|Austria|Belgium|Bulgaria|Germany|Netherlands|Romania|South Africa 1
Australia|Belgium|Germany|Hungary|Iceland|Malta|Poland|Portugal 1
Australia|Germany|New Zealand 1
Austria|Argentina|Australia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan 1
Austria|France|Germany 1
Austria|Germany 1
Belgium 1
Belgium|Czechia|France|Germany|Poland|Spain|United Kingdom 1
Belgium|Denmark|Finland|France|Germany|Hungary|Ireland|Latvia|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Germany|Poland|United Kingdom 1
Bulgaria|Denmark|Poland 1
Bulgaria|Finland|Germany 1
Canada|Denmark|Finland|United Kingdom 1
Canada|Finland|Germany 1
Canada|Israel 1
Chile 1
China|Philippines 1
Czechia|France|Germany|Hungary|Poland 1
Czechia|United States|Canada|Germany|Hungary|Japan|Poland 1
Dominican Republic 1
Egypt 1
France|Germany 1
France|Germany|Poland|United Kingdom 1
France|United States|Australia|Canada|Estonia|Korea, Republic of|Latvia|Lithuania|Spain 1
Germany|Czechia|Denmark|France|India|Italy|Japan|Mexico|Russian Federation|Taiwan 1
Germany|France|United States|Australia|Canada|Poland 1
Germany|Hungary|Poland 1
Germany|Spain|Belgium|United States|Canada|Czechia|France|Italy|Japan|Poland|United Kingdom 1
Germany|United States|Denmark 1
Germany|United States|France|Japan|Spain 1
Hungary 1
Hungary|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czechia|Germany|Israel|Italy|Japan|Korea, Republic of|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|United Kingdom 1
India 1
Indonesia 1
Italy|Germany|United States|Bulgaria|Canada|Mexico|Romania|Singapore|Taiwan|Ukraine 1
Japan|Austria|Belgium|Brazil|Finland|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom 1
Japan|United States|Australia|Canada|Czechia|Hungary|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Spain|United Kingdom 1
Mexico|Venezuela 1
Mongolia 1
Philippines 1
Poland 1
Poland|United Kingdom|Canada|Czech Republic|Germany|Hungary 1
Poland|United States|Australia|Bulgaria|Canada|China|Czechia|Germany|Hungary|Japan|Korea, Republic of|Latvia|United Kingdom 1
Portugal 1
Spain|United States|Australia|Canada|Czechia|Estonia|Germany|Hungary|Japan|Korea, Republic of|Latvia|Poland|Switzerland|Ukraine|United Kingdom 1
United Kingdom|Austria|Belgium|Germany|Ireland|Netherlands|Poland|Russian Federation|Slovakia|Spain 1
United States|American Samoa|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Korea, Republic of|Netherlands|New Zealand|Portugal|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Bosnia and Herzegovina|Bulgaria|Canada|China|Colombia|Croatia|Denmark|Estonia|Finland|France|Germany|Italy|Japan|Malaysia|New Zealand|Puerto Rico|Romania|Russian Federation|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Austria|Belgium|Canada|Czechia|Estonia|Finland|France|Germany|Hungary|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Chile|China|Germany|Israel|Italy|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan 1
United States|Australia 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|China|Czechia|Denmark|Estonia|Finland|France|Germany|Hungary|Ireland|Italy|Japan|Korea, Republic of|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Singapore|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Netherlands|New Zealand|Norway|Puerto Rico|Slovakia|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Canada|China|Spain|Turkey 1
United States|Australia|Austria|Canada|Czechia|Germany|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Finland|Germany|Japan|Netherlands|Spain 1
United States|Australia|Belgium|Canada|France|Germany|Japan|Netherlands|Poland|United Kingdom 1
United States|Australia|Bulgaria|Canada|Chile|Czechia|Germany|Hungary|Italy|Japan|Korea, Republic of|Latvia|Mexico|Poland|Slovakia|Spain|Taiwan|United Kingdom 1
United States|Australia|Bulgaria|Canada|Denmark|Germany|Hungary|Japan|Latvia|Poland 1
United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Canada|Czechia|Finland|France|Germany|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Czechia|Germany|Hungary|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Czechia|Germany|Hungary|Poland|United Kingdom 1
United States|Australia|Canada|Denmark|Italy|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Australia|Canada|Germany|Hungary 1
United States|Australia|Canada|Germany|Hungary|New Zealand 1
United States|Australia|Canada|Germany|Japan|Poland 1
United States|Australia|Canada|Japan|Puerto Rico 1
United States|Australia|China|Czechia|Germany|Hungary|Italy|Japan|Latvia|Mexico|Poland|Spain|Taiwan|United Kingdom 1
United States|Australia|China|New Zealand 1
United States|Australia|Germany|Israel|Spain|Switzerland|United Arab Emirates 1
United States|Australia|Germany|Poland|United Kingdom 1
United States|Australia|New Zealand 1
United States|Australia|Poland 1
United States|Belgium|Bulgaria|Estonia|France|Germany|Hungary|Italy|Korea, Republic of|Poland|Romania|Singapore 1
United States|Belgium|Canada|Germany|Netherlands|Poland|Spain|United Kingdom 1
United States|Belgium|Czechia|Germany|Korea, Republic of|Poland|Spain 1
United States|Belgium|Germany|Italy|Poland|Sweden|Switzerland|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Germany|Lithuania|Poland 1
United States|Bulgaria|Canada|Czechia|Germany|Poland|Spain 1
United States|Canada|Czechia|Germany|Hungary|Poland|United Kingdom 1
United States|Canada|Finland|Germany|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom 1
United States|Canada|France|Germany|Hungary|Italy|Poland 1
United States|Canada|Germany 1
United States|Canada|Germany|Japan 1
United States|Canada|South Africa 1
United States|Dominican Republic|Honduras 1
United States|France|Netherlands 1
United States|Germany 1
United States|Germany|Italy|Japan|Netherlands|Switzerland 1
United States|Honduras|Panama 1
United States|Mexico 1
United States|Norway|Puerto Rico 1
United States|Poland 1
United States|Poland|Canada|Czechia|Germany|United Kingdom 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 239
2 35
3 23
4 13
5 13
6 10
7 11
8 3
9 6
10 7
11 3
12 5
13 11
14 2
15 5
16 2
17 4
18 2
19 4
20 3
21 1
22 5
23 1
24 1
25 2
26 2
27 4
28 2
29 2
30 1
31 4
32 1
33 1
35 2
36 1
38 3
40 1
41 1
42 2
43 2
44 1
45 1
47 1
49 1
51 1
52 2
53 1
57 2
58 1
60 3
63 1
64 1
66 4
67 1
68 1
70 1
72 2
73 1
74 1
75 1
76 1
79 1
80 1
81 1
84 2
87 1
88 1
89 1
90 2
93 1
97 1
102 1
103 1
114 1
115 2
121 2
123 1
136 1
149 1
153 1
159 1
166 1
181 1
185 1
192 1
196 1
216 1
242 1
289 1
434 1
496 1

Phase

Phase Study_Count
Phase 2 171
Phase 3 99
N/A 97
Phase 4 64
Phase 1 46
Phase 1/Phase 2 19
Early Phase 1 4
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 76
2 238
3 70
4 54
5 15
6 11
7 3
8 5
9 2
11 1
13 2
14 1
27 1
NA 24

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 40.0 4.0000 5.00000 23.00000 5.0000 48.00000 20.0000 5.00000
1st Qu. 44.5 23.7500 26.25000 35.00000 48.0000 69.00000 200.0000 29.75000
Median 48.0 56.0000 40.00000 54.00000 103.0000 90.00000 364.0000 50.00000
Mean 48.0 128.3542 81.28261 63.10526 137.3018 79.33333 514.8866 98.93333
3rd Qu. 51.5 101.2500 77.25000 67.00000 204.0000 95.00000 740.0000 117.75000
Max. 56.0 2701.0000 800.00000 221.00000 640.0000 100.00000 3000.0000 600.00000

Trial Group Type

group_type Group_Count
Experimental 764
Placebo Comparator 257
Active Comparator 184
Other 40
No Intervention 28
NA 24
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 360
Single Group Assignment 105
Crossover Assignment 20
Sequential Assignment 11
Factorial Assignment 5
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 432
Prevention 22
Basic Science 15
Supportive Care 10
Other 8
NA 7
Diagnostic 6
Health Services Research 3

Observational Studies

Studies by Country

Country Study_Count
United States 41
NA 4
Germany 3
Korea, Republic of 3
Netherlands 2
Thailand 2
United Kingdom 2
Austria 1
Canada 1
Denmark 1
Finland 1
Hong Kong 1
Indonesia 1
Indonesia|Singapore 1
Kazakhstan 1
Lithuania 1
Poland 1
Russian Federation 1
Singapore 1
Switzerland 1
Taiwan 1
United States|Canada|Chile|Hong Kong|Italy|Netherlands 1

Sites per Study

Site_count Study_Count
1 60
2 7
4 1
7 2
9 1
14 1

Enrollment Metrics

Measure Observational
Min 9.00
1st Qu 45.00
Median 80.00
Mean 20925.18
3rd Qu 404.50
Max 1027559.00

Observation Model

observational_model Study_Count
Cohort 25
Case-Control 12
Case-Only 11
NA 9
Case Control 6
Other 5
Ecologic or Community 2
Defined Population, Natural History 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 49
Cross-Sectional 10
Retrospective 7
Other 2
NA 2
Cross-Sectional, Prospective 1
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
Netherlands 3
United States 3
China 1
Germany 1

Sites per Study

Site_count Study_Count
1 5
3 1
11 1
38 1

Enrollment Metrics

Measure Registries
Min 21.000
1st Qu 156.250
Median 493.500
Mean 2254.125
3rd Qu 750.000
Max 15000.000

Registry Model

observational_model Study_Count
Cohort 6
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 7
Other 1

Follow-up

target_duration Study_Count
5 Years 3
1 Year 1
10 Years 1
12 Months 1
2 Years 1
3 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT01569906 Narrowband UVB for Children With Moderate to Severe Atopic Eczema https://ClinicalTrials.gov/show/NCT01569906 Completed Royal Victoria Infirmary 2010-08-31
NCT01714245 A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients https://ClinicalTrials.gov/show/NCT01714245 Completed TopMD Skin Care, Inc. 2013-12-31
NCT03831646 Clinical, Psychological and Genetic Characteristics in Dermatological Patients https://ClinicalTrials.gov/show/NCT03831646 Completed Astana Medical University 2019-07-10
NCT03823794 Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) https://ClinicalTrials.gov/show/NCT03823794 Active, not recruiting Momentum Data 2020-05-01
NCT03361215 Disease Trajectories in Atopic Dermatitis and Psoriasis https://ClinicalTrials.gov/show/NCT03361215 Recruiting University of Schleswig-Holstein 2027-01-01
NCT03252340 Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03252340 Active, not recruiting EHL Bio Co., Ltd. 2021-08-17
NCT03168113 Atopic Dermatitis (AD) and Food Allergy https://ClinicalTrials.gov/show/NCT03168113 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2018-01-31
NCT03142139 Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age? https://ClinicalTrials.gov/show/NCT03142139 Completed Bandim Health Project 2014-12-31
NCT03112876 Sebum Collection and Skin Barrier Function Analysis https://ClinicalTrials.gov/show/NCT03112876 Completed University of California, Davis 2016-02-26
NCT03003793 Insulin Sensitivity in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03003793 Completed University Hospital, Gentofte, Copenhagen 2016-09-30
NCT02926807 Trial on Vascular Inflammation in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02926807 Completed Innovaderm Research Inc. 2018-11-30
NCT02916888 A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists https://ClinicalTrials.gov/show/NCT02916888 Completed Yale University 2017-12-31
NCT02680405 Identification of Epidermal Signatures in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02680405 Active, not recruiting National Jewish Health 2016-07-31
NCT03038932 Etiology of Eczema Herpeticum (EH) https://ClinicalTrials.gov/show/NCT03038932 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-08-31
NCT00605878 Studies of Skin Microbes in Healthy People and in People With Skin Conditions https://ClinicalTrials.gov/show/NCT00605878 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02552979 Atopy Patch Test in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02552979 Completed Mahidol University 2014-12-31
NCT02532920 The Natural History of Atopic Disease in Thai Children and Association With Atopic March https://ClinicalTrials.gov/show/NCT02532920 Completed Mahidol University 2016-06-30
NCT02401178 The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants https://ClinicalTrials.gov/show/NCT02401178 Completed Indonesia University 2015-12-31
NCT02125695 Pilot Tape Harvesting Study https://ClinicalTrials.gov/show/NCT02125695 Completed Biogen 2016-08-31
NCT02098551 Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments https://ClinicalTrials.gov/show/NCT02098551 Completed Medical University of Vienna 2011-11-30
NCT02091037 S. Aureus Colonization in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02091037 Active, not recruiting Columbia University 2016-12-31
NCT02073591 Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen https://ClinicalTrials.gov/show/NCT02073591 Completed Hyphens Pharma Pte Ltd 2014-11-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT04240522 Prospective Longitudinal Observational Research in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04240522 Recruiting University of Zurich 2020-01-20
NCT01789619 Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT01789619 Completed UMC Utrecht 2014-01-31
NCT01494142 Registry for the Atopic Dermatitis Research Network https://ClinicalTrials.gov/show/NCT01494142 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2018-02-07
NCT01429311 Interferon Responses in Eczema Herpeticum https://ClinicalTrials.gov/show/NCT01429311 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-01-31
NCT04362852 Patient Forward Access to Clinical and Technological Research: Genetic Influences on Lung Cancer and Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04362852 Recruiting Boston Children’s Hospital 2021-02-01
NCT04354207 Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma https://ClinicalTrials.gov/show/NCT04354207 Enrolling by invitation Lithuanian University of Health Sciences 2022-08-01
NCT03490877 Scratch and Sleep Quantification in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03490877 Completed University of Rochester 2019-04-30
NCT04276623 Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment https://ClinicalTrials.gov/show/NCT04276623 Recruiting UMC Utrecht 2022-09-01
NCT04218877 The Factors Affecting Atopic Dermatitis in Children Age 1-3 https://ClinicalTrials.gov/show/NCT04218877 Recruiting Akusherstvo Pro 2020-07-10
NCT04180644 Skin Tape Transcriptome Methods in Children https://ClinicalTrials.gov/show/NCT04180644 Completed National Jewish Health 2020-02-05
NCT04154839 Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04154839 Recruiting The University of Hong Kong 2021-12-31
NCT01995747 The Effect of Anti-CεmX on IgE Production https://ClinicalTrials.gov/show/NCT01995747 Completed National Taiwan University Hospital 2012-06-30
NCT04097327 Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function https://ClinicalTrials.gov/show/NCT04097327 Completed Bitop AG 2019-12-31
NCT04087863 Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT04087863 Recruiting Kang Stem Biotech Co., Ltd. 2022-12-31
NCT04060550 Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum https://ClinicalTrials.gov/show/NCT04060550 Recruiting National Jewish Health 2020-09-01
NCT04008784 Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period https://ClinicalTrials.gov/show/NCT04008784 Recruiting Clinical Research Center of the Carolinas 2020-02-29
NCT03874039 Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03874039 Recruiting Northwestern University 2020-12-31
NCT03813472 Hydration Sensor for Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03813472 Enrolling by invitation Northwestern University 2021-04-30
NCT03770858 Wearable Skin Sensors to Assess Nocturnal Scratch Behavior https://ClinicalTrials.gov/show/NCT03770858 Recruiting Northwestern University 2021-09-30
NCT03411837 Dupilumab Phase 4 Study https://ClinicalTrials.gov/show/NCT03411837 Enrolling by invitation Northwestern University 2020-03-31
NCT01238263 Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01238263 Completed Yuzuncu Yıl University 2010-06-30
NCT01164241 Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways https://ClinicalTrials.gov/show/NCT01164241 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01069666 Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians https://ClinicalTrials.gov/show/NCT01069666 Completed Siriraj Hospital NA
NCT03559075 Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03559075 Completed Wake Forest University Health Sciences 2018-08-08
NCT00879944 Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index https://ClinicalTrials.gov/show/NCT00879944 Completed Northwestern University 2012-06-30
NCT00822276 The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) https://ClinicalTrials.gov/show/NCT00822276 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-11-30
NCT03962387 Evalution the Safety and Efficacy in Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT03962387 Recruiting Kang Stem Biotech Co., Ltd. 2024-01-02
NCT00815984 Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases https://ClinicalTrials.gov/show/NCT00815984 Completed Medical Universtity of Lodz 2010-01-31
NCT01782703 Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01782703 Recruiting Northwestern University 2020-12-31
NCT03800004 Bone Health in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03800004 Recruiting Mayo Clinic 2020-12-30
NCT00713089 Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development https://ClinicalTrials.gov/show/NCT00713089 Completed National University Hospital, Singapore 2009-11-30
NCT00710489 Potential Research Study Participant Registry https://ClinicalTrials.gov/show/NCT00710489 Completed University of California, Davis 2018-09-05
NCT00696397 Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology https://ClinicalTrials.gov/show/NCT00696397 Completed Wake Forest University Health Sciences 2009-12-31
NCT00691366 Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00691366 Completed Wake Forest University Health Sciences 2009-12-31
NCT00660127 The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT00660127 Completed Wake Forest University Health Sciences 2009-12-31
NCT00568997 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus https://ClinicalTrials.gov/show/NCT00568997 Recruiting Bausch Health Americas, Inc. 2026-12-31
NCT00515047 Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00515047 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-01-31
NCT00459576 Risk of Asthma in Infants With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00459576 Completed Indiana University 2012-01-31
NCT00438646 Oral Bacteria and Allergic Disease in Children https://ClinicalTrials.gov/show/NCT00438646 Completed National Institutes of Health Clinical Center (CC) 2008-12-31
NCT00438022 Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00438022 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2010-01-31
NCT00407979 Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis https://ClinicalTrials.gov/show/NCT00407979 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-02-28
NCT00406081 Immune Response to Varicella Vaccination in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00406081 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-09-30
NCT00379678 Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00379678 Completed National Jewish Health 2007-03-31
NCT00001760 Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals https://ClinicalTrials.gov/show/NCT00001760 Completed National Institutes of Health Clinical Center (CC) NA
NCT00277433 Histamine Pharmacogenetics in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00277433 Completed Virginia Commonwealth University 2009-12-31
NCT00275795 NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET® https://ClinicalTrials.gov/show/NCT00275795 Completed Nambudripad’s Allergy Research Foundation NA
NCT00177268 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research https://ClinicalTrials.gov/show/NCT00177268 Recruiting University of Pittsburgh 2027-01-31
NCT00795496 Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up https://ClinicalTrials.gov/show/NCT00795496 Completed University of Helsinki 2010-04-30
NCT00098150 Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00098150 Completed Novartis NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04462055 Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04462055 Recruiting UMC Utrecht 2022-07-01
NCT03661866 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC https://ClinicalTrials.gov/show/NCT03661866 Recruiting Target PharmaSolutions, Inc. 2026-10-31
NCT03057860 TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03057860 Recruiting Technische Universität Dresden 2021-01-31
NCT02889081 Maternal Key Nutritional Factors and Offspring’s Atopic Dermatitis (MKNFOAD) https://ClinicalTrials.gov/show/NCT02889081 Completed Children’s Hospital of Fudan University 2017-10-31
NCT04214548 A Pilot Study to Explore the Role of Gut Flora in Eczema https://ClinicalTrials.gov/show/NCT04214548 Recruiting ProgenaBiome 2023-03-31
NCT04017520 Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children and Toddlers https://ClinicalTrials.gov/show/NCT04017520 Recruiting Milton S. Hershey Medical Center 2021-04-30
NCT03621137 TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies https://ClinicalTrials.gov/show/NCT03621137 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2027-10-31
NCT03549416 BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03549416 Recruiting UMC Utrecht 2028-12-31